Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06870838
What this trial is testing

Neuroinflammation in FTLD

Who this might be right for
Corticobasal Syndrome(CBS)Primary Progressive Aphasia(PPA)Progressive Supranuclear Palsy(PSP)+2 more
Leiden University Medical Center 110
Large-scale testing (Phase 3)WithdrawnNCT00313976
What this trial is testing

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis
Bayer
Not applicableLooking for participantsNCT06667817
What this trial is testing

Exercise From Afar: Progressing At Risk Individuals to Independent Exercise

Who this might be right for
Sedentary Behavior
Emporia State University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06284590
What this trial is testing

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Philogen S.p.A. 162
Not applicableActive Not RecruitingNCT04881617
What this trial is testing

Treatment for Speech and Language in Primary Progressive Aphasia

Who this might be right for
Primary Progressive AphasiaSemantic DementiaSemantic Memory Disorder+4 more
University of Texas at Austin 60
Not applicableLooking for participantsNCT07775235
What this trial is testing

Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseMyositis
Singapore General Hospital 80
Not applicableLooking for participantsNCT06909240
What this trial is testing

Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)

Who this might be right for
Deep Vein Thrombosis (DVT)
Hvidovre University Hospital 152
Testing effectiveness (Phase 2)Study completedNCT04042558
What this trial is testing

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Gene Mutation+2 more
Centre Francois Baclesse 150
Not applicableUnknownNCT04691635
What this trial is testing

The MOTIVE-PSP Initiative (Progressive Supranuclear Palsy)

Who this might be right for
Progressive Supranuclear Palsy
University of Salerno 165
Post-approval studies (Phase 4)UnknownNCT02821689
What this trial is testing

Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis

Who this might be right for
DermatopolymyositisInterstitial Lung Disease
RenJi Hospital 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT01068249
What this trial is testing

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 42
Not applicableStudy completedNCT04140240
What this trial is testing

Menopause Symptom Management in Perimenopause and Postmenopausal Period

Who this might be right for
Menopause
Akdeniz University 60
Very early researchNot Yet RecruitingNCT07384390
What this trial is testing

TH-CAR-027 for Grade 4 Gliomas

Who this might be right for
R/R Grade 4 Glioma
Shanghai Tongji Hospital, Tongji University School of Medicine 21
Testing effectiveness (Phase 2)Looking for participantsNCT07210086
What this trial is testing

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

Who this might be right for
Prostate Cancer
City of Hope Medical Center 50
Not applicableStudy completedNCT01590524
What this trial is testing

Feasibility Study on the Effect of Complementary Methods as Supportive Interventions for Parents of Children With Cancer

Who this might be right for
AnxietyStressMood+1 more
Cyprus University of Technology 52
Testing effectiveness (Phase 2)Study completedNCT02847559
What this trial is testing

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Who this might be right for
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT03432260
What this trial is testing

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Durect 19
Testing effectiveness (Phase 2)Study completedNCT02155920
What this trial is testing

Everolimus for Children With Recurrent or Progressive Ependymoma

Who this might be right for
Recurrent Childhood Ependymoma
University of Texas Southwestern Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT01259388
What this trial is testing

A Pilot Study of Lithium in Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
VA Office of Research and Development 23
Large-scale testing (Phase 3)Study completedNCT02246127
What this trial is testing

Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Neuroendocrine Tumors
Grupo Espanol de Tumores Neuroendocrinos 141
Next Page